Table 2.
Genotype | Tumour
|
MSI incidencea |
Fertility Male/female | Reference | ||
---|---|---|---|---|---|---|
Spectrumb | Incidence | Mononucleotide | Dinucleotide | |||
MutS homologues | ||||||
MSH2−/− | Lymphoma, GI, skin and other tumours | High | High | High | +/+ | de Wind et al. (1995), Reitmair et al. (1995, 1997), Smits et al. (2000) |
MSH2 C674A/C674A | Lymphoma, GI, skin | High | High | High | +/+ | Lin et al. (2004) |
MSH3−/− | GI tumours | Low | Moderate | High | +/+ | Edelmann et al. (2000), de Wind et al. (1999) |
MSH6−/− | Lymphoma, GI, skin and | High | None | Low | +/+ | Edelmann et al. (1997) |
MSH6 TI217D/T1217D | Lymphoma, GI, skin | High | High | High | +/+ | Yang et al. (2004a,b) |
MSH3−/− MSH6−/− | Lymphoma, GI, skin and other tumours | High | High | High | +/+ | Edelmann et al. (2000), de Wind et al. (1999) |
MSH4−/− | None | None | N/A | N/A | −/− | Kneitz et al. (2000) |
MSH5−/− | None | None | N/A | N/A | −/− | Edelmann et al. (1999a), de Vries et al. (1999) |
MutL homologues | ||||||
MLH1−/− | Lymphoma, GI, skin and other tumours | High | High | High | −/− | Baker et al. (1996), Edelmann et al. (1996), Prolla et al. (1998), Edelmann et al. (1999b) |
PMS1−/− | None | None | Low | Low | +/+ | Prolla et al. (1998) |
PMS2−/− | Lymphoma and sarcoma | High | High | High | −/+ | Baker et al. (1995), Prolla et al. (1998) |
MLH3−/− | N/A | N/A | Low | Low | −/−; | Lipkin et al. (2002) |
Exonuclease | ||||||
EXO1−/− | Lymphoma | Moderate | High | Low | −/− | Wei et al. (2003) |
GI tumours: Adenoma, adenocarcinoma, and flat adenoma in gastrointestinal organs. Skin tumours: Squamous cell carcinoma, keratoacanthoma, sebaceous (adenoma, epithelioma, carcinoma), papilloma, haemangioma, and pylomatricoma. Other tumours include: Tumours of the uterus, brain, lung, liver, and mammary gland. Sarcoma: Leiomyosarcoma, myxoid sarcoma, and fibroid sarcoma. Adapted from Edelmann and Edelmann (2004) and used with permission.
MSI was analysed in tumour samples, normal tissue or culture cells.
Tumour spectrum includes: Lymphoma: B and T cell lymphoma (NHL, non-Hodgkin’s lymphoma).